LY 190147
Latest Information Update: 02 Sep 1998
At a glance
- Originator Eli Lilly and Company
- Developer Eli Lilly and Company; Nonindustrial source
- Class Antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Arrhythmias in Canada (Unknown route)
- 02 Sep 1998 No-Development-Reported for Arrhythmias in USA (Unknown route)
- 19 Apr 1996 Preclinical development for Arrhythmias in Canada (Unknown route)